New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Weber, D.J.
    • Affiliation: School of Medicine, Division of Infectious Diseases
  • Sickbert-Bennett, E.E.
    • Affiliation: School of Medicine, Division of Infectious Diseases
  • Kanamori, H.
    • Other Affiliation: Tohoku University
  • Rutala, W.A.
    • Affiliation: School of Medicine, Division of Infectious Diseases
Abstract
  • In the recent past, we have witnessed the emergence of many new infectious diseases, some of which are major public health threats. The public health threats posed by emerging diseases have been well described in 2 reports from the Institute of Medicine, 1 in 1992 and 1 in 2001.1,2 Since the outbreak of Legionella in 19763,4 and AIDS in 19815,6 later demonstrated to be due to HIV in 1983,7 many emerging infectious diseases have had important infection control implications. This review will focus on several of the most important current infection prevention threats including Ebola virus, Middle Eastern respiratory syndrome (MERS) coronavirus (CoV), carbapenem-resistant Enterobacteriaceae (CRE), and Candida auris with a focus on mechanisms of transmission, environmental contamination and stability, and germicide susceptibility. Germicides that will be discussed include chemical sterilants used to process critical equipment and devices (eg, surgical instruments, implants), high-level disinfectants that are used to disinfect semicritical equipment and devices (ie, medical equipment or devices that come into contact with nonintact skin or mucous membranes), low-level disinfectants used for disinfection of surfaces or shared equipment that come into contact with intact skin (eg, blood pressure cuffs, room surfaces), and antiseptics (ie, germicides used on skin or mucous membranes to reduce the microbial flora).8,9 This review updates a previous article that reviewed Ebola and MERS and also reviews CRE and C auris.
Date of publication
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • American Journal of Infection Control
Journal volume
  • 47
Page start
  • A29
Page end
  • A38
Language
  • English
ISSN
  • 0196-6553
Publisher
  • Mosby Inc.

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details 1-s2.0-S0196655319301531-main.pdf 2020-07-22 Public Download